WASHINGTON, Oct. 24, 2019 /PRNewswire/ -- A new report produced by Asset Funders Network (AFN), in collaboration with Yale's Medical School Program for Recovery a

FOREST, Va., Oct. 24, 2019 /PRNewswire/ -- NanoTouch Materials announced broad support for corporate ESG (environmental, social and governance) initiatives as well as UN SDGs (United Nations sustainable development goals) with their line of self-cleaning surfaces for facilities. One of the main categories of initiatives has to do with health and wellness in the bu

DETROIT, Oct. 24, 2019 /PRNewswire/ -- This year's' Hispanic Heritage month takes on advancements in healthcare with the launch of the nation's first all-Spanish language telemedicine service. Michigan is the first territory for Telemedicina Latina offering immediate medical consults with Michigan bas

NEW YORK, Oct. 24, 2019 /PRNewswire/ -- The US Navy Veterans Mesothelioma Advocate say "We are the top branded source in the nation for a US Navy Veteran with mesothelioma and we are passionate about making certain people like this receive the very best possible financial compensation settlement results. We are urging a Navy Veteran with mesothelioma because of asbestos

JERSEY CITY, N.J., Oct. 24, 2019 /PRNewswire/ -- SCYNEXIS, Inc. (NASDAQ:SCYX), a biotechnology company delivering innovative therapies for difficult-to-treat and often life-threatening infections, today announced an amendment to the protocol for the ongoing FURI study investigating the safety and efficacy of oral ibrexafungerp (formerly SCY-078) as a salvage treatme

RANCHO CORDOVA, Calif., Oct. 24, 2019 /PRNewswire/ -- Cesca Therapeutics Inc. (Nasdaq: KOOL), a market leader in automated cell processing and autologous cell therapies for regenerative medicine, today announced Chris Xu, Ph.D., Chairman and Chief Executive Officer, will present a company overview at the Dawson James Securities 5t

SAN DIEGO, Oct. 24, 2019 /PRNewswire/ -- DelMar Pharmaceuticals, Inc. (Nasdaq: DMPI) ("DelMar" or the "Company"), a biopharmaceutical company focused on the developmen

NORTH CHICAGO, Ill., Oct. 24, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, will participate in the Wolfe Research Inaugural Healthcare Conference on Wednesday, November 6.  Richard A. Gonzalez, chairman and chief executive officer, will present at 8:30 a.m. Central

SEATTLE, Oct. 24, 2019 /PRNewswire/ -- Bardy Diagnostics, Inc., ("BardyDx"), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that it was selected as winner of the "Remote Monitoring in Arrhythmias" Technology and Innovation Pitch Session held as part of the

PALO ALTO, Calif., Oct. 24, 2019 /PRNewswire/ -- SightGlass Vision, Inc., a medical device company developing spectacle lenses to slow the progression of nearsightedness or myopia in children, today announced that data from three clinical trials overviewing discovery to clinical development of its novel spectacle lenses will be presented for the first time in a scie